Jennifer Nessel, Assistant Editor

Adult patients with type 2 diabetes requiring insulin therapy can safely achieve good blood sugar control using regular human insulin in a wearable, patch-like insulin delivery device called V-Go.

The amicus brief from the Academy of Managed Care Pharmacy argues that a ruling in favor of Rutledge would drive up health care costs and hinder patients’ ability to access affordable medications.

Eptinezumab-jjmr, the first and only intravenous treatment for migraine prevention, is now commercially available in the United States.

XMT-1536, a first-in-class antibody-drug conjugate NaPi2B was well tolerated with no dose-limiting toxicities in patients with ovarian cancer and non-small cell lung cancer (NSCLC).

Front-line use of vigil immunotherapy as maintenance in stage 3-4 ovarian cancer was well tolerated and demonstrated relapse-free survival clinical benefit.

In a series of studies, researchers described the identification of predictive tools and a new understanding of environmental factors that trigger inflammatory bowel disease.

The American Society of Health-System Pharmacists has launched a new, free service to connect health care facilities with pharmacy personnel who can help alleviate potential staffing shortages.

Study findings suggest that veliparib added to carboplatin and paclitaxel during combination phase may provide anti-tumor activity versus carboplatin and paclitaxel alone.

Homologous recombination deficiency is not predictive of patient outcomes for veliparib-throughout versus control in patients with BRAC wildtype ovarian carcinomas.

New research in 5 human cancer cell lines revealed interdependencies between a tumor and its host’s microenvironment.

The FDA has approved coagulation factor VIIA (recombinant)-jncw (Sevenfact, LFB) for the treatment and control of bleeding episodes occurring in adolescents aged 12 years and older with hemophilia A or B with inhibitors.

The FDA has announced that it is accelerating the development of potentially safe and effective life-saving treatments for patients with the coronavirus 2019 disease.

A recent study has detailed information on the potential dangers and the application of QTc monitoring to guide treatment when using drugs that can cause heart rhythm changes.

Researchers examine how stem cells promote neuronal growth in tissue regeneration and in cancer progression.

In the midst of rapid industry changes and new demands brought by the coronavirus disease 2019 pandemic, pharmacy technicians are taking on new roles and responsibilities.

The American College of Rheumatology addresses the prior authorization requirement for some prescription medications, highlighting the significant burden this creates for patients and rheumatology professionals.

Top news of the week from Pharmacy Times® surrounding the novel coronavirus.

New information from the IQVIA “Global Medicine Spending and Usage Trends” report highlights the expected growth of specialty pharmacy spending by 2024.

The FDA has issued a complete response letter for the supplemental New Drug Application of the investigational medicine empagliflozin 2.5 mg as an adjunct to insulin for adults with type 1 diabetes.

A statistical analysis predicts that more than 70,000 heart attacks, strokes, and other adverse cardiovascular events could be prevented each year in the United States through the use of a highly purified fish oil therapy.

New research has examined the details surrounding the signaling molecule interleukin-2, which could lead to more targeted therapies for diseases such as cancer.

Research may lead to the development of new types of binding proteins for biological sugar structures, which play a significant role in cancer and infectious diseases.

Patients with a history of cancer have a greater likelihood of developing atrial fibrillation, the most common heart rhythm disorder, compared with the general population.

Pennsylvania Governor Tom Wolf’s administration has decided that in-state and out-of-state health care providers can treat patients via telemedicine during the coronavirus disease 2019 pandemic.

Hoth Therapeutics and Voltron Therapeutics will collaborate to develop the self-assembling vaccine technology as a means to aid patients at risk of being infected with COVID-19.

As the role of pharmacists grows into a new phase, the role of the pharmacy technician is expanding as well.

The FDA has issued a new guidance to sponsors and health care providers regarding certain Risk Evaluation and Mitigation Strategy-required testing during the coronavirus disease 2019 pandemic.

A new commentary suggests that public health leaders should guide world leaders through the coronavirus disease 2019 pandemic.

Statins, widely used to lower cholesterol and prevent heart disease, may guard against heart damage caused by certain breast cancer therapies.

CVS mistakenly sent unproven information to employees surrounding drinking warm water to combat the novel coronavirus.